Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome. Graeme L Fraser et al

18/08/2021,
Serge Rozenberg
No data was found

Latest news

20/11/2023
prediction models for primary ovarian insufficiency (POI) in long-term survivors of childhood cancer by Cindy Im et al Lancet Oncol 2023 Nov 13